Various Pathology Supplies to include Pathology Laboratory Reagent, Auxiliary Reagents, Hemostasis Analyzers, Screening Test, Disposables and Accessories
Award Notice Posted
- Solicitation number
- W81K0218Q0114
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to BMI
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81K0218D0009 Federal IDV award
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Not on record
- Place of performance
- Department of Pathology 121st Combat Support Hospital/Brian Allgood Army Community Hospital Unit #15244 Apo Ap 96205 Korea, South
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Awarded Vendors: BMI. Contract Award Dollar Amount: $2,540,280.00. Contract Award Date: 2018-10-01.
Update #1 ·
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
The Regional Health Contracting Office - Pacific, Bldg 339 Clark Road, Fort Shafter, HI 96858, intends to solicit, negotiate, and award a BRAND NAME OR EQUAL Indefinite Delivery Indefinite Quantity (IDIQ) contract for Pathology Laboratory Reagent, Auxiliary Reagents, Hemostasis Analyzers, Screening Test, Disposables and Accessories for the Department of Pathology, 121st CSH/BAACH, Korea.
This is a Request for Quote (RFQ). This solicitation number is W81K0218Q0114, which will be solicited as full and open competition. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-98. The Standard Industrial Classification Code is 6515, size standard is 1,250 employees and the NAICS code of 325413.
Provisions at 52.212-1, Instructions to Quoters - Commercial, and its addendum applies to this acquisition and a statement regarding any addenda to the provision. See Enclosure 1.
Quoters shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications - Commercial Items, with its quote.
The clause 52.212-4, Contract Terms and Conditions - Commercial Items, and its addendum applies to this acquisition. See Enclosure 1.
The deviation to clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executives Orders - Commercial Items, applies to this acquisition. See Enclosure 1 for FAR clauses that are applicable to this acquisition.
The Defense Priorities and Allocations System (DPAS) and assigned rating is not applicable.
The Government intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract.
Contract Requirements - The successful quoter shall be required to provide Pathology Laboratory Reagent, Auxiliary Reagents, Hemostasis Analyzers, Screening Test, Disposables and Accessories listed under Salient Characteristics.
Point of contact for this solicitation is Mr. Tae Kim; (808) 438-5131, email: tae.h.kim76.civ@mail.mil
Responses must be received by August 3, 2018 @ 10:00 A.M. HST.
.
Files
| File | Type | Posted |
|---|---|---|
| A.09.02_Enclosure_1_SOL.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity